What the company does
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products …
What the weekly tape is saying
GRF closed the latest completed week at 9.00 EUR. The 4-week return is -1.3% and the 12-week return is 1.5%. Trend Signal is inactive, Market Dynamics is -0.00. Setup signature: Risk-first tape with a 23/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 10.02 EUR
- Vs Trend Line
- -10.1%
- Fair Value
- 10.36 EUR
- Vs Fair Value
- -13.2%
- 52W High
- 13.44 EUR
- 52W Low
- 8.48 EUR
- Drawdown
- -33.0%
- Range Position
- 10.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 21
- 52W Active Breadth
- 40.4%
- Sector Scope
- AT Healthcare
- Sector Rank
- 56 of 112
- Sector Percentile
- 50.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AT Healthcare
- Tracked Peers
- 100
- 4W Rank
- 80 of 100
- Avg 1W
- -1.0%
- Avg 4W
- 3.6%
- Trend Breadth
- 35.0%
- Positive MD
- 42.0%
AT Drug Manufacturers - General
- Tracked Peers
- 17
- 4W Rank
- 14 of 17
- Avg 1W
- -0.8%
- Avg 4W
- 2.5%
- Trend Breadth
- 58.8%
- Positive RS
- 17.6%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.00
- 4W MD Change
- 99.5%
- Relative Strength
- -32.04
- 4W RS Change
- -13.4%
- Expectation
- Undecided
- Probability
- 51.65%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 0
- 13W Average
- 88
- 52W Average
- 23
- Vs 13W
- -
- Vs 52W
- -
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.0%
- 52W Volatility
- 3.8%
- Upside Weeks
- 26
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 2.8% / -3.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- VIE
- Country
- AT
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- EUR
- Market Cap
- 6.4B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 9.00 EUR | -0.9% | 10.02 EUR | 10.36 EUR | -0.00 | -32.04 | 0 | Off |
| 5 Jun 2026 | 9.08 EUR | -4.2% | 10.07 EUR | 10.38 EUR | -0.21 | -30.04 | 0 | Off |
| 29 May 2026 | 9.48 EUR | -0.9% | 10.11 EUR | 10.39 EUR | -0.46 | -28.24 | 0 | Off |
| 22 May 2026 | 9.57 EUR | 5.0% | 10.17 EUR | 10.40 EUR | -0.70 | -25.93 | 0 | Off |
| 15 May 2026 | 9.12 EUR | 2.3% | 10.23 EUR | 10.41 EUR | -0.93 | -28.25 | 0 | Off |
| 8 May 2026 | 8.91 EUR | 0.1% | 10.32 EUR | 10.42 EUR | -0.98 | -30.43 | 0 | Off |
| 1 May 2026 | 8.90 EUR | -0.6% | 10.43 EUR | 10.43 EUR | -0.99 | -29.66 | 0 | Off |
| 24 Apr 2026 | 8.95 EUR | -7.0% | 10.55 EUR | 10.43 EUR | -1.03 | -29.05 | 0 | Off |
| 17 Apr 2026 | 9.63 EUR | 7.6% | 10.65 EUR | 10.43 EUR | -1.08 | -26.65 | 0 | Off |
| 10 Apr 2026 | 8.95 EUR | -2.3% | 10.73 EUR | 10.42 EUR | -1.19 | -30.40 | 1.1K | Off |
| 3 Apr 2026 | 9.16 EUR | 5.1% | 10.84 EUR | 10.43 EUR | -1.22 | -24.43 | 0 | Off |
| 27 Mar 2026 | 8.71 EUR | -1.8% | 10.94 EUR | 10.43 EUR | -0.98 | -25.89 | 0 | Off |
| 20 Mar 2026 | 8.87 EUR | -4.4% | 11.06 EUR | 10.43 EUR | -0.72 | -23.70 | 0 | Off |
| 13 Mar 2026 | 9.28 EUR | -8.9% | 11.17 EUR | 10.43 EUR | -0.33 | -21.50 | 0 | Off |